bio
-
Ligand Recognition Mechanism of Protein Identified
Professor Hak-Sung Kim
-“Solved the 50 year old mystery of how protein recognises and binds to ligands”
- Exciting potential for understanding life phenomena and the further development of highly effective therapeutic agent development
KAIST’s Biological Science Department’s Professor Hak-Sung Kim, working in collaboration with Professor Sung-Chul Hong of Department of Physics, Seoul National University, has identified the mechanism of how the protein recognizes and binds to ligands within the human body.
The research findings were published in the online edition of Nature Chemical Biology (March 18), which is the most prestigious journal in the field of life science.
Since the research identified the mechanism, of which protein recognises and binds to ligands, it will take an essential role in understanding complex life phenomenon by understanding regulatory function of protein.
Also, ligand recognition of proteins is closely related to the cause of various diseases. Therefore the research team hopes to contribute to the development of highly effective treatments.
Ligands, well-known examples include nucleic acid and proteins, form the structure of an organism or are essential constituents with special functions such as information signalling.
In particular, the most important role of protein is recognising and binding to a particular ligand and hence regulating and maintaining life phenomena. The abnormal occurrence of an error in recognition of ligands may lead to various diseases.
The research team focused on the repetition of change in protein structure from the most stable “open form” to a relatively unstable “partially closed form”.
Professor Kim’s team analysed the change in protein structure when binding to a ligand on a molecular level in real time to explain the ligand recognition mechanism.
The research findings showed that ligands prefer the most stable protein structure. The team was the first in the world to identify that ligands alter protein structure to the most stable, the lowest energy level, when it binds to the protein.
In addition, the team found that ligands bind to unstable partially-closed forms to change protein structure.
The existing models to explain ligand recognition mechanism of protein are “Induced Custom Model”, which involves change in protein structure in binding to ligands, and the “Structure Selection Model”, which argues that ligands select and recognise only the best protein structure out of many. The academic world considers that the team’s research findings have perfectly proved the models through experiments for the first time in the world.
Professor Kim explained, “In the presence of ligands, there exists a phenomenon where the speed of altering protein structure is changed. This phenomenon is analysed on a molecular level to prove ligand recognition mechanism of protein for the first time”. He also said, “The 50-year old mystery, that existed only as a hypothesis on biology textbooks and was thought never to be solved, has been confirmed through experiments for the first time.”
Figure 1: Proteins, with open and partially open form, recognising and binding to ligands.
Figure 2: Ligands temporarily bind to a stable protein structure, open form, which changes into the most stable structure, closed form. In addition, binding to partially closed form also changes protein structure to closed form.
2013.04.01 View 12018 -
Top Ten Ways Biotechnology Could Improve Our Everyday Life
The Global Agenda Council on Biotechnology, one of the global networks under the World Economic Forum, which is composed of the world’s leading experts in the field of biotechnology, announced on February 25, 2013 that the council has indentified “ten most important biotechnologies” that could help meet rapidly growing demand for energy, food, nutrition, and health. These new technologies, the council said, also have the potential to increase productivity and create new jobs.
“The technologies selected by the members of the Global Agenda Council on Biotechnology represent almost all types of biotechnology.Utilization of waste, personalized medicine,and ocean agricultureare examples of the challenges where biotechnology can offer solutions,”said Sang Yup Lee, Chair of the Global Agenda Council on Biotechnology and Distinguished Professor in the Department of Chemical and Biomolecular Engineering at the Korea Advanced Institute of Science and Technology (KAIST). He also added that “the members of the council concluded that regulatory certainty, public perception, and investment are the key enablers for the growth of biotechnology.”
These ideas will be further explored during “Biotechnology Week” at the World Economic Forum’s Blog (http://wef.ch/blog) from Monday, 25 February, 2013. The full list follows below:
Bio-based sustainable production of chemicals, energy, fuels and materials
Through the last century, human activity has depleted approximately half of the world’s reserves of fossil hydrocarbons. These reserves, which took over 600 million years to accumulate, are non-renewable and their extraction, refining and use contribute significantly to human emissions of greenhouse gases and the warming of our planet. In order to sustain human development going forward, a carbon-neutral alternative must be implemented. The key promising technology is biological synthesis; that is, bio-based production of chemicals, fuels and materials from plants that can be re-grown.
Engineering sustainable food production
The continuing increase in our numbers and affluence are posing growing challenges to the ability of humanity to produce adequate food (as well as feed, and now fuel). Although controversial, modern genetic modification of crops has supported growth in agricultural productivity. In 2011, 16.7 million farmers grew biotechnology-developed crops on almost 400 million acres in 29 countries, 19 of which were developing countries. Properly managed, such crops have the potential to lower both pesticide use and tilling which erodes soil.
Sea-water based bio-processes
Over 70% of the earth surface is covered by seawater, and it is the most abundant water source available on the planet. But we are yet to discover the full potential of it. For example with halliophic bacteria capable of growing in the seawater can be engineered to grow faster and produce useful products including chemicals, fuels and polymeric materials. Ocean agriculture is also a promising technology. It is based on the photosynthetic biomass from the oceans, like macroalgae and microalgae.
Non-resource draining zero waste bio-processing
The sustainable goal of zero waste may become a reality with biotechnology. Waste streams can be processed at bio-refineries and turned into valuable chemicals and fuels, thereby closing the loop of production with no net waste. Advances in biotechnology are now allowing lower cost, less draining inputs to be used, including methane, and waste heat. These advances are simplifying waste streams with the potential to reduce toxicity as well as support their use in other processes, moving society progressively closer to the sustainable goal of zero waste.
Using carbon dioxide as a raw material
Biotechnology is poised to contribute solutions to mitigate the growing threat of rising CO2 levels. Recent advances are rapidly increasing our understanding of how living organisms consume and use CO2. By harnessing the power of these natural biological systems, scientists are engineering a new wave of approaches to convert waste CO2 and C1 molecules into energy, fuels, chemicals, and new materials.
Regenerative medicine
Regenerative medicine has become increasingly important due to both increased longevity and treatment of injury. Tissue engineering based on various bio-materials has been developed to speed up the regenerative medicine. Recently, stem cells, especially the induced pluripotent stem cells (iPS), have provided another great opportunity for regenerative medicine. Combination of tissue engineering and stem cell (including iPS) technologies will allow replacements of damaged or old human organs with functional ones in the near future.
Rapid and precise development and manufacturing of medicine and vaccines
A global pandemic remains one of the most real and serious threats to humanity. Biotechnology has the potential to rapidly identify biological threats, develop and manufacture potential cures. Leading edge biotechnology is now offering the potential to rapidly produce therapeutics and vaccines against virtually any target. These technologies, including messenger therapeutics, targeted immunotherapies, conjugated nanoparticles, and structure-based engineering, have already produced candidates with substantial potential to improve human health globally.
Accurate, fast, cheap, and personalized diagnostics and prognostics
Identification of better targets and combining nanotechnology and information technology it will be possible to develop rapid, accurate, personalized and inexpensive diagnostics and prognostics systems.
Bio-tech improvements to soil and water
Arable land and fresh water are two of the most important, yet limited, resources on earth. Abuse and mis-appropriation have threatened these resources, as the demand on them has increased. Advances in biotechnology have already yielded technologies that can restore the vitality and viability of these resources. A new generation of technologies: bio-remediation, bio-regeneration and bio-augmentation are being developed, offering the potential to not only further restore these resources, but also augment their potential.
Advanced healthcare through genome sequencing
It took more than 13 years and $1.5 billion to sequence the first human genome and today we can sequence a complete human genome in a single day for less than $1,000. When we analyze the roughly 3 billion base pairs in such a sequence we find that we differ from each other in several million of these base pairs. In the vast majority of cases these difference do not cause any issues but in rare cases they cause disease, or susceptibility to disease. Medical research and practice will increasingly be driven by our understanding of such genetic variations together with their phenotypic consequences.
2013.03.19 View 12387 -
An efficient strategy for developing microbial cell factories by employing synthetic small regulatory RNAs
A new metabolic engineering tool that allows fine control of gene expression level by employing synthetic small regulatory RNAs was developed to efficiently construct microbial cell factories producing desired chemicals and materials
Biotechnologists have been working hard to address the climate change and limited fossil resource issues through the development of sustainable processes for the production of chemicals, fuels and materials from renewable non-food biomass. One promising sustainable technology is the use of microbial cell factories for the efficient production of desired chemicals and materials. When microorganisms are isolated from nature, the performance in producing our desired product is rather poor. That is why metabolic engineering is performed to improve the metabolic and cellular characteristics to achieve enhanced production of desired product at high yield and productivity. Since the performance of microbial cell factory is very important in lowering the overall production cost of the bioprocess, many different strategies and tools have been developed for the metabolic engineering of microorganisms.
One of the big challenges in metabolic engineering is to find the best platform organism and to find those genes to be engineered so as to maximize the production efficiency of the desired chemical. Even Escherichia coli, the most widely utilized simple microorganism, has thousands of genes, the expression of which is highly regulated and interconnected to finely control cellular and metabolic activities. Thus, the complexity of cellular genetic interactions is beyond our intuition and thus it is very difficult to find effective target genes to engineer. Together with gene amplification strategy, gene knockout strategy has been an essential tool in metabolic engineering to redirect the pathway fluxes toward our desired product formation. However, experiment to engineer many genes can be rather difficult due to the time and effort required; for example, gene deletion experiment can take a few weeks depending on the microorganisms. Furthermore, as certain genes are essential or play important roles for the survival of a microorganism, gene knockout experiments cannot be performed. Even worse, there are many different microbial strains one can employ. There are more than 50 different E. coli strains that metabolic engineer can consider to use. Since gene knockout experiment is hard-coded (that is, one should repeat the gene knockout experiments for each strain), the result cannot be easily transferred from one strain to another.
A paper published in Nature Biotechnology online today addresses this issue and suggests a new strategy for identifying gene targets to be knocked out or knocked down through the use of synthetic small RNA. A Korean research team led by Distinguished Professor Sang Yup Lee at the Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), a prestigeous science and engineering university in Korea reported that synthetic small RNA can be employed for finely controlling the expression levels of multiple genes at the translation level. Already well-known for their systems metabolic engineering strategies, Professor Lee’s team added one more strategy to efficiently develop microbial cell factories for the production of chemicals and materials.
Gene expression works like this: the hard-coded blueprint (DNA) is transcribed into messenger RNA (mRNA), and the coding information in mRNA is read to produce protein by ribosomes. Conventional genetic engineering approaches have often targeted modification of the blueprint itself (DNA) to alter organism’s physiological characteristics. Again, engineering the blueprint itself takes much time and effort, and in addition, the results obtained cannot be transferred to another organism without repeating the whole set of experiments. This is why Professor Lee and his colleagues aimed at controlling the gene expression level at the translation stage through the use of synthetic small RNA. They created novel RNAs that can regulate the translation of multiple messenger RNAs (mRNA), and consequently varying the expression levels of multiple genes at the same time. Briefly, synthetic regulatory RNAs interrupt gene expression process from DNA to protein by destroying the messenger RNAs to different yet controllable extents. The advantages of taking this strategy of employing synthetic small regulatory RNAs include simple, easy and high-throughput identification of gene knockout or knockdown targets, fine control of gene expression levels, transferability to many different host strains, and possibility of identifying those gene targets that are essential.
As proof-of-concept demonstration of the usefulness of this strategy, Professor Lee and his colleagues applied it to develop engineered E. coli strains capable of producing an aromatic amino acid tyrosine, which is used for stress symptom relief, food supplements, and precursor for many drugs. They examined a large number of genes in multiple E. coli strains, and developed a highly efficient tyrosine producer. Also, they were able to show that this strategy can be employed to an already metabolically engineered E. coli strain for further improvement by demonstrating the development of highly efficient producer of cadaverine, an important platform chemical for nylon in the chemical industry.
This new strategy, being simple yet very powerful for systems metabolic engineering, is thus expected to facilitate the efficient development of microbial cell factories capable of producing chemicals, fuels and materials from renewable biomass.
Source: Dokyun Na, Seung Min Yoo, Hannah Chung, Hyegwon Park, Jin Hwan Park, and Sang Yup Lee, “Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs”, Nature Biotechnology, doi:10.1038/nbt.2461 (2013)
2013.03.19 View 10503
-
Op-Ed by Professor David Helfman: Global Science and Education in Korea for the 21st Century
Professor David Helfman from the Department of Biological Sciences and Graduate School of Nanoscience and Technology contributed an op-ed, “Global Science and Education in Korea for the 21st Century, to the Korea Herald on February 20, 2013. For the article, please click the link below:
http://www.koreaherald.com/view.php?ud=20130220000623.
2013.02.26 View 10817
-
2013 Graduation Ceremony Held on February 22
KAIST held a graduation ceremony for the year 2013 at Ryu Keun-Chul Sports Complex on February 22nd.
A total of 2,475 academic degrees were awarded this day, including 482 doctoral degrees, 1,153 master’s degrees, 838 bachelor’s degrees, and two honorary doctorates to Dr. Han Seung-Soo, a former prime minister of South Korea, and Lee Soo-young, the chairwoman of Kwang Won Industrial Co. Ltd. This commencement made KAIST to have turned out overall 46,117 talented graduates – 9,383 doctorates, 23,941 master’s degrees, and 12,793 bachelor’s degrees – to the fields of science and technology since its establishment in 1971.
The Minister of Education and Science Technology Award, which is for the student receiving bachelor’s degree with the highest academic performance, was given to Seung-Uk Jang from the Department of Mathematical Sciences. In addition, the Chairman of the KAIST Board of Trustees Award was given to Chi-Heon Kwon from the Department of Chemistry, KAIST Presidential Award to Yong-Jin Park from the Department of Chemical and Biomolecular Engineering, President of Alumni Association Award to Bong-Soo Choi from the Department Electrical Engineering, and School Supporting Association’s Award to Bo-Kyung Kim from the Bio and Brain Engineering Department.
“Climate changes due to humanity’s economic activities are threatening crucial resources such as water, food, and energy security,” said Former Prime Minister Han Seung-Soo, who received an honorary doctorate at the commencement ceremony. “Please try to solve the greatest issues that human society is facing,” he entreated in his congratulatory message.
“Use the excellent education that you have received at KAIST wisely with good purpose and ethics,” also congratulated President Suh Nam-Pyo. “I hope the graduating students of KAIST to become global leaders in the near future,” he said to the graduates entering the society.
“It was a great honor to contribute as the president of KAIST for almost 7 years, which has been the most challenging and worthwhile time in my life,” he delivered words of gratitude to all members of KAIST. “I appreciate everyone’s efforts for KAIST to develop so far.”
President Suh completed his duty as the fourteenth president of KAIST with the ceremony and returned to the United States on the 25th.
2013.02.26 View 9526 -
Prof. Jong Chul Ye Appointed as the Editor of IEEE TIP
Professor Jong Chul Ye
KAIST Bio & brain engineering department’s Professor Jong Chul Ye has been appointed as the editor of the "IEEE image processing transactions (IEEE TIP, IEEE Transaction on Image Processing)’, a prominent journal in the sector of imaging and medical image processing.
Professor Ye will act as the editor in the field of medical imaging from February 2013 to January 2016, during which he will participate in examining thesis, establishing the direction of the journal and more.
Professor Jong Chul Ye was recognized for his notable work in the field of medical imaging research using compressed sensing for the development of a high resolution medical image reconstruction techniques. This technique has pioneered a new area that is applicable in magnetic resonance imaging (MRI), computed tomography (CT), positron emission Camcorder (PET) and brain imaging.
On the other hand, “IEEE TIP” was first published in 1992 and is currently the world’s leading authority in the field of image processing, medical imaging, image acquisition, compression and output.
2013.02.21 View 10704
-
New BioFactory Technique Developed using sRNAs
Professor Sang Yup Lee
- published on the online edition of Nature Biotechnology. “Expected as a new strategy for the bio industry that may replace the chemical industry.”-
KAIST Chemical & Biomolecular engineering department’s Professor Sang Yup Lee and his team has developed a new technology that utilizes the synthetic small regulatory RNAs (sRNAs) to implement the BioFactory in a larger scale with more effectiveness.
* BioFactory: Microbial-based production system which creates the desired compound in mass by manipulating the genes of the cell.
In order to solve the problems of modern society, such as environmental pollution caused by the exhaustion of fossil fuels and usage of petrochemical products, an eco-friendly and sustainable bio industry is on the rise. BioFactory development technology has especially attracted the attention world-wide, with its ability to produce bio-energy, pharmaceuticals, eco-friendly materials and more.
For the development of an excellent BioFactory, selection for the gene that produces the desired compounds must be accompanied by finding the microorganism with high production efficiency; however, the previous research method had a complicated and time-consuming problem of having to manipulate the genes of the microorganism one by one.
Professor Sang Yup Lee’s research team, including Dr. Dokyun Na and Dr. Seung Min Yoo, has produced the synthetic sRNAs and utilized it to overcome the technical limitations mentioned above.
In particular, unlike the existing method, this technology using synthetic sRNAs exhibits no strain specificity which can dramatically shorten the experiment that used to take months to just a few days.
The research team applied the synthetic small regulatory RNA technology to the production of the tyrosine*, which is used as the precursor of the medicinal compound, and cadaverine**, widely utilized in a variety of petrochemical products, and has succeeded developing BioFactory with the world’s highest yield rate (21.9g /L, 12.6g / L each).
*tyrosine: amino acid known to control stress and improve concentration
**cadaverine: base material used in many petrochemical products, such as polyurethane
Professor Sang Yup Lee highlighted the significance of this research: “it is expected the synthetic small regulatory RNA technology will stimulate the BioFactory development and also serve as a catalyst which can make the chemical industry, currently represented by its petroleum energy, transform into bio industry.”
The study was carried out with the support of Global Frontier Project (Intelligent Bio-Systems Design and Synthesis Research Unit (Chief Seon Chang Kim)) and the findings have been published on January 20th in the online edition of the worldwide journal Nature Biotechnology.
2013.02.21 View 11727
-
KAIST welcomes Dr. Sung-Mo
The KAIST Board of Trustees appointed Distinguished Chair Professor Sung-Mo "Steve" Kang of Electrical Engineering at the University of California, Santa Cruz, as the 15th President of KAIST on January 31, 2013. President Kang has begun the duties of his office on February 23, 2013.
An acclaimed scientist, professor, and entrepreneur in the field of integrated-circuit design, Dr. Sung-Mo "Steve" Kang has earned a worldwide reputation for his outstanding research achievements. He led the development of the world’s first full 32-bit CMOS microprocessor chips and their peripheral chips, as well as designed satellite-based private communication networks while working at AT&T Bell Laboratories as a technical supervisor of high-end microprocessor design group (1977-1985).
Dr. Sung-Mo "Steve" Kang served as Chancellor of the University of California, Merced, from 2007 to 2011. During his tenure, he has increased student enrollment, improved the national and international visibility of the university, secured financial resources, expanded faculty and staff, and enhanced campus infrastructure.
Before joining UC Merced, Dr. Kang was Dean of Baskin School of Engineering and Professor of Electrical Engineering during 2001-2007 at UC Santa Cruz where he had initiated several interdisciplinary programs in such areas as biomolecular engineering, information systems and technology management, biomimetic microelectronic systems, quantitative biomedical research, and bioinformatics. He also served as President of Silicon Valley Engineering Council, the alliance for engineering leaders in Silicon Valley (2002-2003).
Dr. Sung-Mo "Steve" Kang was Head of the Department of Electrical and Computer Engineering at the University of Illinois at Urbana-Champaign from 1995 to 2000. He is a fellow of the Institute of Electrical and Electronics Engineers (IEEE), the Association for Computing Machinery (ACM), and the American Association for the Advancement of Science (AAAS), and the president of the IEEE Circuits and Systems Society. Dr. Kang was the founding editor-in-chief of the IEEE Transactions on Very Large Scale Systems (1992-1994).
Dr. Sung-Mo "Steve" Kang holds 15 U.S. patents and has written or co-authored nine books and more than 350 technical papers, and won numerous awards, among others, the Silicon Valley Engineering Hall of Fame (2009), ISQED Quality Award by the International Society for Quality Electronic Design (2008), Chang-Lin Tien Education Leadership Award (2007), IEEE Mac Van Valkenburg Award (2005), and Alexander von Humboldt Award for Senior US Scientists (1997). As an entrepreneur, he co-founded a fabless mobile memory chip design company, ZTI, which is currently located in San Jose, the US.
Dr. Kang earned his doctorate from the University of California, Berkeley; a Master of Science degree from the State University of New York at Buffalo, and a Bachelor of Science degree, graduating summa cum laude, from Fairleigh Dickinson University in Teaneck, NJ. All his academic degrees are in electrical engineering.
2013.02.19 View 12101 -
Op-Ed by Prof. David Helfman: Global Science and Education in the 21st Century
Professor David Helfman from the Department of Biological Sciences and Graduate School of Nanoscience and Technology(https://sites.google.com/site/cellsignalinglaboratory/home) recently wrote an Op-Ed in the January 2013 issue of Journal of Happy Scientists and Engineers that ispublished by the Ministry of Science, Education and Technology, the Republic of Korea. In the article entitled “Global Science and Education in the 21st Century,” Professor Helfman addressed three important issues in science and education, which will have a great impact for the development of world-leading universities in Korea. For the article, please see the attachment.
2013.01.22 View 12600
-
KAIST Alumni Association Selects 'Proud Alums'
KAIST Alumni Association selected ‘Proud Alums’ who have contributed to the development of Korea and society and brought honor to KAIST.
The Alums selected were: CEO of Hyundai Heavy Industry Lee Jae Seong, Vice President of SK Hynix Park Sang Hoon, President of Samsung Display Kim Ki Nam, Director of Korea Research Institute of Standards and Science Kang Dae Lim, and President of Dawonsys Park Sun Soon.
Lee Jae Song (Department of Industrial and Systems Engineering, M.S. 3rd) has led Hyundai Heavy Industries through innovation and had contributed in the development of Korea and oversaw the growth of Hyundai Heavy Industries to number 1 in Shipbuilding.
Park Sang Hoon (Biological and Chemical Engineering, M.S. 5th) has led SK Hynix in the fields of energy, chemical and biological medicine and oversaw the development of world class R&D and production technologies to aid the development of Korea.
Kim Ki Nam (Electrical and Electronic Engineering, M.S. 9th) has led the development of innovative semiconductor technologies thereby helping strengthening the competitiveness of Korean semiconductor industry.
Kang Dae Lim (Mechanical Engineering, Ph.D. 1994 graduate) has helped in the development of Korean science and technology by leading the field of measurement standardization as Chairman of International Measurement Confederation and Chairman of Korea Association of Standards & Testing Organizations.
Park Sun Soon (Electrical and Electronic Engineering, M.S. 12th) has succeeded in advancing the field of electronics by pioneering the field of creative technology.
2013.01.22 View 10287
-
Professor Cho Young-ho wins 'E2 Star' award
Professor Cho Young-ho from the Department of Bio and Brain Engineering at KAIST was chosen as the ‘E2 Star’ at the ‘2012 Engineering Education Festa’ in academics. The ‘2012 Engineering Education Festa’ hosted by the Ministry of Education, Science and Technology was held to display outstanding research results and to conceptualize the future of science education.
The ‘E2 star’ award is given to renowned figures in industry, academia and society. A total of 35 candidates were recommended for the 3 fields and Professor Cho received the first place in the online voting.
Professor Cho received high marks for his work in engineering education, research development and increasing the communication between academia and industry, as well as the commercialization of science and technology. Professor Cho was especially praised for the specialization of engineering education in integrated fields and the joint research with US and Swiss universities.
Professor Cho Young-ho(Department of Bio and Brain Engineering, KAIST)
2012.12.26 View 11003 -
High Efficiency Bio-butanol production technology developed
KAIST and Korean Company cooperative research team has developed the technology that increases the productivity of bio-butanol to equal that of bio-ethanol and decreases the cost of production.
Professor Lee Sang Yeop (Department of Biological-Chemical Engineering) collaborated with GS Caltex and BioFuelChem Ltd. to develop a bio-butanol production process using the system metabolism engineering method that increased the productivity and decreased the production cost.
Bio-butanol is being widely regarded as the environmentally friendly next generation energy source that surpasses bio-ethanol.
The energy density of bio-butanol is 29.9MJ (mega Joule) per Liter, 48% larger than bio-ethanol (19.6MJ) and comparable to gasoline (32MJ). Bio-butanol is advantageous in that it can be processed from inedible biomass and is therefore unrelated to food crises.
Especially because bio-butanol shows similar characteristics especially in its octane rating, enthalpy of vaporization, and air-fuel ratio, it can be used in a gasoline engine.
However barriers such as difficulty in gene manipulation of producer bacterium and insufficient information prevented the mass production of bio-butanol.
Professor Lee’s team applied the system metabolism engineering method that he had invented to shift the focus to the production pathway of bio-butanol and made a new metabolism model.
In the new model the bio-butanol production pathway is divided into the hot channel and the cold channel.
The research team focused on improving the efficiency of the hot channel and succeeded in improving the product yield of 49% (compared to theoretical yield) to 87%.
The team furthered their research and developed a live bio-butanol collection and removal system with GS Caltex. The collaboration succeeded in producing 585g of butanol using 1.8kg of glucose at a rate of 1.3g per hour, boasting world’s highest concentration, productivity, and rate and improving productivity of fermentation by three fold and decreasing costs by 30%.
The result of the research was published in world renowned ‘mBio’ microbiology journal.
2012.12.21 View 9443